At $881M market cap, AEBI screens statistically cheap on a Forward P/E of 8.6 and Price/Sales of 0.4, but the headline discount is masking fragility. The trailing P/E of 67.1 combined with an Altman Z-Score of 1.6 signals balance sheet stress and earnings instability rather than clean growth acceleration. The collapse from EPS of 15.8 to an estimated $0.17 next year is not a growth setup—it’s a reset, and the market is pricing in volatility and financial risk. This is not a classic mispricing; it’s a cyclical industrial trading at a discount because its fundamentals are thin and leverage is high.